Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate for organ failure prevention in traumatic haemorrhage (Phase 2a)
2015-000301-40Phase 2Terminated
- Sponsor
- Queen Mary University of London
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple organ dysfunction syndrome (MODS), Bleeding and psychological trauma comparing Artesunate arm with Placebo arm (2 arms). Primary endpoint: Sequential Organ Failure Assessment (SOFA) score at 48 hours. Started Nov 2015; status: terminated.
02
Drugs
artesunate
03
Conditions
multiple organ dysfunction syndrome (MODS)Bleedingpsychological trauma
Beyond the preview
Go deeper on 2015-000301-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000301-40.